Metal organic framework nano-material as well as preparation method and application thereof

By developing metal organic framework nanomaterials composed of Ce4+ ions and fumaric acid, the poor stability of cholesterol ester hydrolase and lipid uptake problems in the prior art are solved, and lipid outflow is increased, lipid uptake is reduced, and foam cells are reduced. Formulate and effectively alleviate the progress of atherosclerosis.

CN119019704AActive Publication Date: 2024-11-26SHANXI MEDICAL UNIV

Patent Information

Application Number
CN202411212516.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-30
Publication Date
2024-11-26
Estimated Expiration
2044-08-30

AI Technical Summary

Technical Problem

The prior art is difficult to effectively inhibit the progress of atherosclerosis, especially because the cholesterol ester hydrolase in macrophages has poor stability, high price, low recycling rate, and limited efficacy by increasing the lipid efflux mechanism, which cannot be reduced at the same time. Lipid uptake and oxidation of LDL induced foam cell formation.

Method used

Develop a metal organic frame nanomaterial, using a molar ratio of Ce4+ ions to fumaric acid of 5:1, with cholesterol ester hydrolase activity and intrinsic antioxidant activity, and 50-200nm nanoparticles were prepared by the preparation method. Used to increase lipid efflux and reduce lipid uptake and reduce foam cell formation induced by oxidized LDL.

Benefits of technology

It provides a simple and efficient MOF nanomaterial with excellent CEH effectivity and intrinsic antioxidant activity, which can effectively increase lipid outflow, reduce lipid uptake, reduce foam cell formation, and thus reduce atherosclerosis.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119019704A_ABST
    Figure CN119019704A_ABST
Patent Text Reader

Abstract

The invention discloses a metal organic framework nano-material and a preparation method and application thereof, belongs to the technical field of biological nano-materials, solves the technical problem of inhibition of atherosclerosis by metal organic framework bionic nano-enzymes, and adopts the technical scheme that the MOF nano-material is composed of metal ions Ce < 4 + > and ligand fumaric acid in a molar ratio of 5: 1; the preparation method comprises the following steps: measuring the FA regulator and water to prepare a mixed solution, then dropwise adding fumaric acid and ceric ammonium nitrate into the mixed solution, stirring at room temperature, then carrying out centrifugal treatment, alternately and repeatedly washing with water and ethanol, and finally drying in a vacuum oven overnight. The invention provides a simple, efficient and convenient method for synthesizing the MOF nano-material, and the synthesized MOF nano-material has excellent CEH quasi-enzymatic activity and intrinsic antioxidant activity, and can be applied to increase lipid outflow, reduce lipid uptake and reduce ox-LDL induced foam cell formation so as to relieve atherosclerosis.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of biological nanomaterials, and specifically relates to a metal organic framework nanomaterial and a preparation method and application thereof. Background Art

[0002] Atherosclerosis (AS) is an inflammatory immune and lipid metabolic disease. The cardiovascular and cerebrovascular diseases (such as coronary heart disease, stroke, myocardial infarction, etc.) caused by it are the leading causes of death and disability worldwide. Therefore, the treatment of atherosclerosis plays a vital role in combating cardiovascular diseases. The hallmark of the development of atherosclerosis is the formation and accumulation of foam cells rich in cholesterol esters under the endothelium of the affected arteries. The formation of foam cells is mainly due to the imbalance of lipid uptake, lipid processing and reverse cholesterol transport. In the plaque stage and later progression stage of atherosclerosis, a large amount of unlipidated free cholesterol accumulates outside the cells and is mainly excreted from the body through reverse cholesterol transport (RCT) with high-density lipoprotein (HDL) as the carrier. A large number of studies have shown that damage to macrophage RCT accelerates the progression of atherosclerosis, while enhancing macrophage RCT can prevent or even regress atherosclerosis. Since cholesterol exists in the foam cells formed by macrophages mainly in the form of a combination with fatty acids - cholesterol esters, studies have used natural cholesterol ester hydrolase (CEH) to improve atherosclerosis. However, the complex preparation of natural enzymes, poor stability, high prices, and low recycling rates make this method very challenging. In addition, the efficacy of improving atherosclerosis by only increasing lipid outflow, a single lipid downregulation mechanism, is limited, because macrophages will continue to ingest lipids to become foam cells, so it is necessary to reduce lipid uptake at the same time.

[0003] Macrophages are the main source of foam cells, and oxidized low-density lipoprotein (ox-LDL), as a modified low-density lipoprotein, is considered to be the main apolipoprotein accumulated during the formation of foam cells. A large number of literatures have shown that the content of ox-LDL in plaques is closely related to oxidative stress induced by high levels of reactive oxygen species (ROS). In general, intracellular ROS modify LDL to produce ox-LDL, which suggests that reducing the generation of ROS in plaques to inhibit the formation of ox-LDL may attenuate atherosclerosis. In recent years, nanoparticles with natural enzyme-like catalytic activity have attracted widespread attention due to their high stability, low cost, and convenient preparation. Most importantly, nanozymes can reasonably integrate multiple types of enzyme activities compared with natural enzymes and traditional enzyme mimics.

[0004] Metal-organic frameworks (MOFs) are a new type of porous inorganic-organic hybrid materials composed of metal ions / clusters and organic ligands. Due to the advantages of diverse metal ion and ligand structures, high specific surface area, efficient drug loading, and high safety, MOF-based nanozymes have shown broad application prospects and have been widely used to scavenge free radicals and treat ROS-mediated ischemic stroke, rheumatoid arthritis, radiation damage and other diseases. However, nanozymes with CEH mimetic activity are rarely found; moreover, few people pay attention to the treatment of atherosclerosis by nanozymes themselves. Therefore, new MOF materials with both CEH mimetic activity and intrinsic antioxidant activity should be developed to increase lipid efflux and reduce lipid uptake, reduce ox-LDL-induced foam cell formation, and thus alleviate atherosclerosis. Summary of the invention

[0005] The main purpose of the present invention is to overcome the deficiencies in the prior art and solve the technical problem of metal organic framework bionic nanozymes inhibiting atherosclerosis. The present invention provides a metal organic framework nanomaterial and a preparation method and application thereof.

[0006] The present invention is achieved through the following technical solutions: A metal organic framework nano material, characterized in that: the composition and proportion of the metal organic framework nano material are: the metal ion is Ce 4+ ions, ligands are fumaric acid, Ce 4+ The molar ratio of ions to fumaric acid is 5:1.

[0007] Furthermore, the metal organic framework nanomaterial has cholesterol ester hydrolase activity and intrinsic antioxidant activity.

[0008] A method for preparing a metal organic framework nanomaterial comprises the following steps: S1. Measure 1.132 mL to 18.68 mL of formic acid regulator and water to prepare a mixed solution with a volume of 30 mL, and mix the formic acid regulator and water evenly; S2, 1.74 g of fumaric acid and 1.6447 g of ammonium cerium nitrate were added dropwise to the mixed solution prepared in step S1, stirred at room temperature for 10 minutes, then centrifuged at 4000 rpm for 5 minutes, and finally washed repeatedly three times with water and ethanol alternately to obtain a solid material; S3. Dry the solid material prepared in step S2 in a vacuum oven at 60° C. overnight to obtain a metal organic framework nanomaterial.

[0009] Furthermore, in step S3, the size range of the prepared metal organic framework nanomaterial is 50-200 nm, and the more the amount of formic acid regulator added in step S1, the larger the size of the prepared metal organic framework nanomaterial.

[0010] An application of the metal organic framework nanomaterial as described above comprises: Application in the preparation of drugs for alleviating atherosclerosis; Application in the preparation of drugs for increasing lipid efflux and reducing lipid uptake; Application in the preparation of drugs for reducing macrophages and foam cells in endothelial cells.

[0011] The beneficial effects of the present invention are: The present invention provides a simple, efficient and convenient method for synthesizing MOF nanomaterials. The synthesized MOF nanomaterials have excellent CEH pseudoenzyme activity and intrinsic antioxidant activity, increase lipid outflow and reduce lipid uptake, reduce ox-LDL-induced foam cell formation, and thus alleviate atherosclerosis. BRIEF DESCRIPTION OF THE DRAWINGS

[0012] Figure 1 This is a transmission electron microscope photo of the MOF nanomaterial prepared in Example 1; Figure 2 A high-angle annular dark-field scanning transmission electron microscope (HAADF-STEM) photograph of the MOF nanomaterial prepared in Example 1; Figure 3 This is an X-ray photoelectron spectroscopy (XPS) graph of the MOF nanomaterial prepared in Example 1; Figure 4 This is a test diagram of the CEH pseudo-enzyme activity of the MOF nanomaterial prepared in Example 1; Figure 5 This is a SOD activity test diagram of the MOF nanomaterial prepared in Example 1; Figure 6 This is a CAT activity test diagram of the MOF nanomaterial prepared in Example 1; Figure 7 This is a biosafety test diagram of the MOF nanomaterial prepared in Example 1; Figure 8 This is a test diagram of the antioxidant performance of the MOF nanomaterial prepared in Example 1; Fig. 9 This is a test diagram of the MOF nanomaterial prepared in Example 1 to remove excess ROS generated in cells; Fig.10 This is a test diagram of the MOF nanomaterial prepared in Example 1 inhibiting the formation of foam cells; Fig.11 This is a transmission electron microscope photo of the MOF nanomaterial prepared in Example 2; Fig.12 This is a transmission electron microscope photograph of the MOF nanomaterial prepared in Example 3. DETAILED DESCRIPTION

[0013] The present invention is further described in detail below in conjunction with the accompanying drawings and embodiments. Example 1

[0014] A method for preparing a metal organic framework nanomaterial comprises the following steps: S1. Measure 2.264 mL of formic acid (FA) regulator and 27.736 mL of water to prepare a mixed solution with a volume of 30 mL, and mix the FA regulator and water evenly; S2, 1.74 g (15 mmol) of fumaric acid (FMA) and 1.6447 g (15 mmol) of cerium ammonium nitrate Ce(NH4)2(NO3)2 were added dropwise to the mixed solution prepared in step S1, stirred at room temperature for 10 minutes, then centrifuged at 4000 rpm for 5 minutes, and finally washed repeatedly three times with water and ethanol alternately to obtain a solid material; S3. Dry the solid material prepared in step S2 in a vacuum oven at 60° C. overnight to obtain a metal organic framework (MOF) nanomaterial.

[0015] The composition and ratio of the MOF nanomaterial prepared in Example 1 are as follows: the metal ion is Ce 4+ ions, ligands are FMA, Ce 4+ The molar ratio of ions to FMA was 5:1.

[0016] Figure 1 This is a transmission electron microscope photo of the MOF nanomaterial prepared in Example 1. Figure 1 It can be seen that MOF nanomaterials were successfully synthesized with a particle size of 100nm and slight aggregation.

[0017] Figure 2 This is a high-angle annular dark field scanning transmission electron microscope (HAADF-STEM) photograph of the MOF nanomaterial prepared in Example 1. Figure 2 It can be seen that its main elements are Ce, C, and O.

[0018] The application of MOF nanomaterials in the preparation of drugs for alleviating atherosclerosis, in particular, the preparation of MOF nanomaterials for alleviating apolipoprotein E deficiency (ApoE - / - ) Application of MOF nanomaterials in drugs for the treatment of atherosclerosis in mice, because MOF nanomaterials have excellent CEH activity and intrinsic antioxidant activity, they can be used to increase lipid efflux and reduce lipid uptake, thereby reducing foam cells (ox-LDL-induced foam cells) in macrophages and endothelial cells, as follows.

[0019] 1. CEH enzyme activity test of MOF nanomaterials 1) Experimental principle: Cholesterol ester is first hydrolyzed into free cholesterol and fatty acids under the catalysis of cholesterol ester hydrolase. The free monomer is further oxidized with oxygen under the action of cholesterol oxidase to produce H2O2 and cholesterenone. The content of free cholesterol is then determined by detecting the absorbance of resorufin, the reaction product of H2O2 and Amplex Red, in which natural cholesterol ester hydrolase is used as a positive control.

[0020] 2) Prepare a cholesterol benzoate solution (50 μmol) and add cholesterol ester hydrolase or MOF nanomaterial solutions of different concentrations (0, 50, 100 and 200 μg / mL); 3) Add cholesterol detection liquid, incubate at 37℃ in the dark for 30 minutes, and detect the absorbance at 570nm.

[0021] 2. Superoxide dismutase (SOD) activity test of MOF nanomaterials 1) Xanthine (1 mM) and xanthine oxidase (0.1 U / mL) were used as O2• - Generate system; 2) React MOF nanomaterial solutions with different concentrations (0, 50, 100 and 200 μg / mL) with the above system at 37°C for 30 minutes; 3) Detection of residual O2 - The concentration of O2• - cleaning ability.

[0022] 3. Catalase (CAT) activity test of MOF nanomaterials 1) CAT activity, i.e., the hydroxyl radical scavenging ability of MOF nanomaterials, was obtained by measuring the inhibition degree of 2-hydroxyterephthalic acid; 2) Mix 0.5 mM terephthalic acid, 10 mM H2O2, MOF nanomaterial solutions of different concentrations (0, 50, 100 and 200 μg / mL), and 25 mM pH = 7.4 phosphate buffer and react at 37 ° C for 24 hours; 3) Since terephthalic acid itself has no fluorescence, it can capture hydroxyl radicals to form 2-hydroxyterephthalic acid with strong fluorescence. This oxidation product is excited at 320nm and has an emission wavelength of 425nm, so the fluorescence spectrum at 425nm under the excitation wavelength of 320nm is collected.

[0023] 4. Biocompatibility testing of MOF nanomaterials 1) Human umbilical vein endothelial cells (HUVEC) were cultured at 1×10 4 The cells were seeded into 96-well plates at a density of 1 / well and incubated at 37 oC and 5% CO2 atmosphere overnight; 2) Remove the upper culture medium and add 100 μL of fresh culture medium containing 0, 0.78, 1.56, 3.12, 6.25, 12.5, 25, 50, 100 and 200 μg / mL of MOF nanomaterials, respectively, and incubate for 24 hours; 3) Add 10 µL of CCK-8 solution to each well, incubate for 2 hours, and measure the absorbance at 450 nm to calculate the cell activity.

[0024] 5. Antioxidant performance test of MOF nanomaterials 1) To detect the ability of MOF nanomaterials to remove excess reactive oxygen free radicals (ROS) produced in cells, HUVEC were cultured at 4×10 4 The cells were seeded into 24-well plates at a density of 1 / well and incubated at 37 o C and 5% CO2 atmosphere overnight; 2) Remove the upper culture medium, add culture medium containing different concentrations (0, 50, 100 and 200 μg / mL) of MOF nanomaterials and culture for 4 hours, then add serum-free culture medium with H2O2 concentration of 60 μM to induce oxidative damage. 3) After 20 hours, add 10 μL of CCK-8 solution to each well, incubate for 2 hours, and measure the absorbance at 450 nm to calculate the cell activity; 4) If used for taking fluorescent photos, 2 hours after step 2, gently wash the cells twice with PBS to remove the old solution, add freshly prepared 2',7'-dichlorofluorescein (DCF, 10µM) dye to each well and incubate for 2 hours, and take cell fluorescence pictures with an inverted fluorescence microscope.

[0025] 6. Test on the inhibition of foam cell formation by MOF nanomaterials 1) HUVEC were cultured at 2×10 4 The cells were seeded into 12-well plates at a density of 1 / well and incubated at 37 o C and 5% CO2 atmosphere overnight; 2) Remove the upper culture medium, stimulate with lipopolysaccharide (LPS, 1 µg / mL) for 24 hours, and then add culture medium containing different concentrations (0, 50, 100 and 200 μg / mL) of MOF nanomaterials for co-culture.

[0026] 3) After 2 hours, the cells were incubated with 50 µg / mL ox-LDL for 48 hours. The normal control group was treated with fresh culture medium, and the model group was stimulated with ox-LDL only. 4) After 48 hours, cells were stained with Oil Red O (ORO) kit and observed under optical microscope.

[0027] The above-mentioned one to six MOF nanomaterial performance test results are analyzed as follows: Figure 3 This is the X-ray photoelectron spectrum (XPS) of the MOF nanomaterial prepared in Example 1. Ce can be obtained by peak calculation. 4+ The atomic percentage of Ce is 86.8%, 3+ The atomic percentage is 13.2%.

[0028] Figure 4 This is a test diagram of the CEH pseudo-enzyme activity of the MOF nanomaterial prepared in Example 1. Figure 4 It can be seen that MOF nanomaterials can effectively remove cholesterol esters in a concentration-dependent manner.

[0029] Figure 5 This is the SOD activity test diagram of the MOF nanomaterial prepared in Example 1. Figure 5 It can be seen that MOF nanomaterials can effectively remove ROS in a concentration-dependent manner.

[0030] Figure 6 This is the CAT activity test diagram of the MOF nanomaterial prepared in Example 1. Figure 6 It can be seen that MOF nanomaterials can remove H2O2 well in a concentration-dependent manner.

[0031] Figure 7 This is a biosafety test diagram of the MOF nanomaterial prepared in Example 1. Figure 7 It can be seen that after MOF nanomaterials were co-incubated with HUVECs cells for 24 hours, the cell survival rate was above 80%, indicating that MOF nanomaterials have good biosafety.

[0032] Figure 8 This is a test diagram of the antioxidant performance of the MOF nanomaterial prepared in Example 1. Figure 8 It can be seen that the activity of HUVECs cells decreased after H2O2 treatment, but the addition of MOF nanomaterials can effectively resist the damage caused by H2O2 to the cells.

[0033] Fig. 9 This is a test diagram of the MOF nanomaterial prepared in Example 1 to remove excess ROS generated in cells. Fig. 9 As shown in the figure, the fluorescence intensity of HUVECs cells was the highest after H2O2 treatment, indicating that excessive ROS were produced, while the fluorescence intensity of HUVECs cells was significantly reduced after MOF nanomaterial treatment, indicating that the degree of cell oxidation can be effectively inhibited. This shows that MOF nanomaterials can effectively inhibit the generation of ROS, thereby protecting cells from oxidative stress.

[0034] Fig.10This is a test diagram of the MOF nanomaterial prepared in Example 1 inhibiting the formation of foam cells. Fig.10 As shown, ox-LDL stimulation causes cells to produce many lipid droplets and induces the formation of foam cells. However, after treatment with MOF nanomaterials, the formation of foam cells can be greatly reduced. Example 2

[0035] A method for preparing a metal organic framework nanomaterial comprises the following steps: S1. Measure 1.132 mL of FA regulator and 29.887 mL of water to prepare a mixed solution with a volume of 30 mL, and mix the FA regulator and water evenly; S2, 1.74 g (15 mmol) of FMA and 1.6447 g (15 mmol) of Ce(NH4)2(NO3)2 were added dropwise to the mixed solution prepared in step S1, stirred at room temperature for 10 minutes, then centrifuged at 4000 rpm for 5 minutes, and finally washed repeatedly three times with water and ethanol alternately to obtain a solid material; S3. Dry the solid material prepared in step S2 in a vacuum oven at 60° C. overnight to obtain MOF nanomaterials.

[0036] The composition and ratio of the MOF nanomaterial prepared in Example 2 are as follows: the metal ion is Ce 4+ ions, ligands are FMA, Ce 4+ The molar ratio of ions to FMA was 5:1.

[0037] Fig.11 This is a transmission electron microscope photo of the MOF nanomaterial prepared in Example 2. Fig.11 It can be seen that the particle size is 50nm and there is slight aggregation.

[0038] The MOF nanomaterial prepared in this Example 2 has the same cholesterol ester hydrolase activity and intrinsic antioxidant activity as the MOF nanomaterial prepared in Example 1, which can increase the efflux of lipids and reduce the uptake of lipids, and reduce the formation of foam cells in macrophages and endothelial cells. Example 3

[0039] A method for preparing a metal organic framework nanomaterial comprises the following steps: S1. Measure 18.68 mL of FA regulator and 11.32 mL of water to prepare a mixed solution with a volume of 30 mL, and mix the FA regulator and water evenly; S2, 1.74 g (15 mmol) of FMA and 1.6447 g (15 mmol) of Ce(NH4)2(NO3)2 were added dropwise to the mixed solution prepared in step S1, stirred at room temperature for 10 minutes, then centrifuged at 4000 rpm for 5 minutes, and finally washed repeatedly three times with water and ethanol alternately to obtain a solid material; S3. Dry the solid material prepared in step S2 in a vacuum oven at 60° C. overnight to obtain MOF nanomaterials.

[0040] The composition and proportion of the MOF nanomaterial prepared in Example 3 are as follows: the metal ion is Ce 4+ ions, ligands are FMA, Ce 4+ The molar ratio of ions to FMA was 5:1.

[0041] Fig.12 This is a transmission electron microscope photo of the MOF nanomaterial prepared in Example 3. Fig.12 It can be seen that the particle size is 200 nm and there is slight aggregation.

[0042] The MOF nanomaterial prepared in this Example 3 has the same cholesterol ester hydrolase activity and intrinsic antioxidant activity as the MOF nanomaterial prepared in Examples 1 and 2, and can increase the efflux of lipids and reduce the uptake of lipids, thereby reducing the formation of foam cells in macrophages and endothelial cells.

[0043] The above is only a specific embodiment of the present invention, but the protection scope of the present invention is not limited thereto. Any changes or substitutions that can be easily thought of by a person skilled in the art within the technical scope disclosed by the present invention should be included in the protection scope of the present invention. Therefore, the protection scope of the present invention shall be based on the protection scope of the claims.

Claims

1. A metal organic framework nanomaterial, characterized in that: The composition and proportion of the metal organic framework nanomaterial are as follows: the metal ion is Ce 4+ ions, ligands are fumaric acid, Ce 4+ The molar ratio of ions to fumaric acid is 5:

1.

2. The metal organic framework nanomaterial according to claim 1, characterized in that: The metal organic framework nanomaterial has cholesterol ester hydrolase activity and intrinsic antioxidant activity.

3. A method for preparing the metal organic framework nanomaterial as claimed in claim 1, characterized in that: The following steps are involved: S1. Measure 1.132-18.68 mL of formic acid regulator and water to prepare a mixed solution with a volume of 30 mL, and mix the formic acid regulator and water evenly; S2, 1.74 g of fumaric acid and 1.6447 g of ammonium cerium nitrate were added dropwise to the mixed solution prepared in step S1, stirred at room temperature for 10 minutes, then centrifuged at 4000 rpm for 5 minutes, and finally washed repeatedly three times with water and ethanol alternately to obtain a solid material; S3. Dry the solid material prepared in step S2 in a vacuum oven at 60° C. overnight to obtain a metal organic framework nanomaterial.

4. The method for preparing a metal organic framework nanomaterial according to claim 3, characterized in that: In the step S3, the size of the prepared metal organic framework nanomaterial is in the range of 50-200 nm, and the more the amount of formic acid regulator added in the step S1 is, the larger the size of the prepared metal organic framework nanomaterial is.

5. An application of the metal organic framework nanomaterial as claimed in claim 1, characterized in that: The metal organic framework nanomaterial is used in preparing a drug for alleviating atherosclerosis.

6. An application of the metal organic framework nanomaterial as claimed in claim 1, characterized in that: The metal organic framework nanomaterial is used in preparing drugs for increasing lipid efflux and reducing lipid uptake.

7. An application of the metal organic framework nanomaterial as claimed in claim 1, characterized in that: The metal organic framework nano material is used in preparing medicine for reducing macrophages and foam cells in endothelial cells.

Citation Information

Patent Citations

  • Organic metal frameworks nano material, and preparation and application thereof

    CN112755183A

  • Bionic nano-enzyme as well as preparation method and application thereof

    CN114768872A

  • Application of MOF nano-enzyme

    CN114796269A

  • Application of metal organic framework material Ce-MOF-808 in radiation protection

    CN115227714A

Cited By

  • Nano-enzyme based on tin selenide as well as preparation method and application of nano-enzyme

    CN122075531A

  • Metal-organic framework nanomaterial, preparation therefor and use thereof

    WO2026045510A1